$1.85
-$0.02
(-1.07%)
Quote as of 3:59 PM EST on 02/14/12
ACADIA Pharmaceuticals, Inc.
NASDAQ:ACAD
|
$1.85
-$0.02
(-1.07%)
|
|
| Today's Open | $1.87 |
|---|---|
| Previous Close | $1.87 |
| Daily Range | $1.82 - $1.88 |
| 52-Week Range | $0.90 - $3.30 |
| Market Cap | $97.68M |
| P/E Ratio | 4.45 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 326,223 |
| Average Daily Volume | 401,403 |
| Current FY EPS | -$0.44 |
ACAD Information
| Description |
|---|
| The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Zacks #1 Rank Additions for Wednesday - Tale of the Tape
Zacks #1 Rank Additions for Monday - Tale of the Tape
Zacks #1 Rank Additions for Thursday - Tale of the Tape
Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Zacks #1 Rank Additions for Friday - Tale of the Tape
US Stock Futures: HOT STOCKS TO WATCH
Acadia Pharmaceuticals: Investing With No Safety Net
Dream Stocks: April's Strongest Performers
Optimistic on Acadia: Solid Cash Position, Increased Confidence in Phase 3 Trial
